| 4D MOLECULAR THERAPEUTICS IN | COM | $1.1M | 0.1% | 116,712 SH | New |
| A SPAC III ACQUISITION CORP | RIGHT 01/02/2026 | $42K | 0.0%Prev: 0.0% | 215,000 SH | Increased |
| ABIVAX SA | SPONSORED ADS | $160.1M | 9.4%Prev: 2.6% | 1,438,019 SH | Increased-772,000 SH |
| ACHIEVE LIFE SCIENCE INC | COM | $141K | 0.0% | 47,800 SH | New |
| ACLARIS THERAPEUTICS INC | COM | $497K | 0.0% | 132,426 SH | New |
| ACUMEN PHARMACEUTICALS INC | COM | $5.1M | 0.3%Prev: 0.0% | 2,156,334 SH | Increased+2,010,151 SH |
| ADAGIO MED HLDGS INC | COM | $1.4M | 0.1%Prev: 0.0% | 1,205,447 SH | Increased+1,128,690 SH |
| ADICET BIO INC | COM NEW | $367K | 0.0% | 53,827 SH | New |
| ADLAI NORTYE LTD | SPONSORED ADS | $816K | 0.0% | 117,909 SH | New |
| AGIOS PHARMACEUTICALS INC | COM | $4.8M | 0.3%Prev: 0.2% | 140,672 SH | Increased+112,772 SH |
| ALECTOR INC | COM | $2.3M | 0.1%Prev: 0.1% | 1,050,000 SH | Increased+669,670 SH |
| ALEXANDRIA REAL ESTATE EQ IN | COM | $905K | 0.1% | 19,500 SH | New |
| ALIBABA GROUP HLDG LTD | SPONSORED ADS | $449K | 0.0% | 3,578 SH | New |
| ALKERMES PLC | SHS | $1.6M | 0.1% | 46,400 SH | New |
| AMERICAN EXCEPTIONALISM ACQU | ORD CL A | $3.9M | 0.2% | 357,539 SH | New |
| AMICUS THERAPEUTIC | COM | $1.5M | 0.1% | 105,000 SH | New |
| AMYLYX PHARMACEUTICALS INC | COM | $13.9M | 0.8%Prev: 1.0% | 1,000,604 SH | Increased-470,983 SH |
| AN2 THERAPEUTICS INC | COM | $47K | 0.0% | 13,861 SH | New |
| ANAPTYSBIO INC | COM | $205K | 0.0% | 3,698 SH | New |
| ANNEXON INC | COM | $305K | 0.0% | 55,000 SH | New |
| ANTERIS TECHNOLOGIES GLOBAL | COM | $21.0M | 1.2%Prev: 1.1% | 3,789,132 SH | Increased+2,111,069 SH |
| APELLIS PHARMACEUTICALS INC | COM | $2.9M | 0.2%Prev: 0.1% | 72,500 SH | Increased+55,500 SH |
| AQUESTIVE THERAPEUTICS INC | COM | $42K | 0.0% | 10,000 SH | New |
| ARBUTUS BIOPHARMA CORP | COM | $14.1M | 0.8%Prev: 1.2% | 3,133,175 SH | Increased+1,254,061 SH |
| ARCELLX INC | COMMON STOCK | $3.7M | 0.2%Prev: 0.2% | 32,084 SH | Increased+18,122 SH |
| ARCTURUS THERAPEUTICS HLDGS | COM | $116K | 0.0% | 15,000 SH | New |
| ARDELYX INC | COM | $143K | 0.0%Prev: 0.4% | 23,900 SH | Decreased-466,843 SH |
| ARRIVENT BIOPHARMA INC | COM | $3.3M | 0.2% | 141,814 SH | New |
| ARROWHEAD PHARMACEUTICALS IN | COM | $4.4M | 0.3%Prev: 0.1% | 70,300 SH | Increased+14,000 SH |
| ARROWHEAD PHARMACEUTICALS IN | NOTE 1/1 | $1.0M | 0.1% | 10,000 SH | New |
| ARS PHARMACEUTICALS INC | COM | $10.9M | 0.6% | 1,361,536 SH | New |
| ARVINAS INC | COM | $610K | 0.0%Prev: 0.4% | 57,591 SH | Decreased-255,763 SH |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $5.7M | 0.3%Prev: 0.0% | 25,014 SH | Increased+23,612 SH |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $554K | 0.0% | 19,947 SH | New |
| ATAIBECKLEY INC | COM SHS | $3.2M | 0.2% | 913,242 SH | New |
| ATRIUM THERAPEUTICS INC | COM | $771K | 0.0% | 57,688 SH | New |
| ATYR PHARMA INC | COM NEW | $40K | 0.0% | 50,685 SH | New |
| AVANTOR INC | COM | $627K | 0.0% | 80,000 SH | New |
| BEAM THERAPEUTICS INC | COM | $34.5M | 2.0% | 1,446,375 SH | New |
| BELITE BIO INC | SPONSORED ADS | $4.3M | 0.3% | 26,880 SH | New |
| BENITEC BIOPHARMA INC | COM NEW | $186K | 0.0% | 17,500 SH | New |
| BEONE MEDICINES LTD | SPONSORED ADS | $3.5M | 0.2% | 11,701 SH | New |
| BEST SPAC I ACQUISITION CORP | UNIT 05/27/2030 | $1.0M | 0.1% | 100,000 SH | New |
| BHAV ACQUISITION CORP | UNIT 03/18/2031 | $4.9M | 0.3% | 495,000 SH | New |
| BICARA THERAPEUTICS INC | COM | $273K | 0.0% | 13,705 SH | New |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | $331K | 0.0% | 71,298 SH | New |
| BIOAGE LABS INC | COM | $2.4M | 0.1%Prev: 0.7% | 135,560 SH | Decreased-835,540 SH |
| BIOATLA INC | COM | $37K | 0.0% | 228,107 SH | New |
| BIOCRYST PHARMACEUTICALS INC | COM | $1000K | 0.1%Prev: 0.0% | 105,000 SH | Increased+95,000 SH |
| BIOGEN INC | COM | $2.0M | 0.1%Prev: 0.1% | 11,000 SH | Increased+6,500 SH |
| BIOHAVEN LTD | COM | $379K | 0.0%Prev: 0.1% | 44,777 SH | Decreased+22,136 SH |
| BIOMARIN PHARMACEUTICAL INC | COM | $1.0M | 0.1%Prev: 0.1% | 18,200 SH | Increased+13,300 SH |
| BIOMEA FUSION INC | COM | $66K | 0.0% | 43,420 SH | New |
| BIONTECH SE | SPONSORED ADS | $889K | 0.1%Prev: 0.1% | 10,000 SH | Increased+5,000 SH |
| BOSTON SCIENTIFIC CORP | COM | $628K | 0.0% | 10,000 SH | New |
| BRIDGEBIO PHARMA INC | COM | $7.0M | 0.4%Prev: 2.2% | 94,292 SH | Decreased-245,343 SH |
| BRIDGEBIO PHARMA INC | NOTE 1.750% 3/0 | $4.9M | 0.3%Prev: 0.5% | 30,000 PRN | Increased-2,636,627 PRN |
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | $4.9M | 0.3%Prev: 0.7% | 45,000 PRN | Increased-4,455,000 PRN |
| BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | $3.6M | 0.2%Prev: 0.4% | 20,000 PRN | Increased-1,980,000 PRN |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | $2.5M | 0.1% | 33,900 SH | New |
| BRIGHTHOUSE FINL INC | COM | $5.7M | 0.3% | 95,523 SH | New |
| BRISTOL-MYERS SQUIBB CO | COM | $1.1M | 0.1% | 17,500 SH | New |
| C4 THERAPEUTICS INC | COM STK | $113K | 0.0% | 43,000 SH | New |
| CANTOR EQUITY PARTNERS VI IN | CL A ORD SHS | $202K | 0.0% | 20,000 SH | New |
| CAPRICOR THERAPEUTICS INC | COM NEW | $2.8M | 0.2% | 90,593 SH | New |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $13.6M | 0.8%Prev: 0.0% | 427,816 SH | Increased+413,216 SH |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $1.5M | 0.1%Prev: 0.6% | 38,566 SH | Decreased-177,600 SH |
| CG ONCOLOGY INC | COM | $12.6M | 0.7%Prev: 1.4% | 185,699 SH | Increased-115,435 SH |
| CHEMOMAB THERAPEUTICS LTD | SPONSORED ADS | $126K | 0.0% | 80,000 SH | New |
| CLIMB BIO INC | COM | $4.1M | 0.2%Prev: 0.0% | 597,662 SH | Increased+478,342 SH |
| CLOVER HEALTH INVESTMENTS CO | COM CL A | $70K | 0.0%Prev: 0.0% | 40,000 SH | Decreased+11,700 SH |
| COHEN CIRCLE ACQUISIT CORP I | UNIT 07/01/2030 | $1.6M | 0.1% | 150,000 SH | New |
| COHERUS ONCOLOGY INC | COM | $18K | 0.0% | 10,366 SH | New |
| COMPASS THERAPEUTICS INC | COM | $735K | 0.0% | 139,000 SH | New |
| CONNECT BIOPHARMA HLDGS LTD | SHS | $1.9M | 0.1% | 742,400 SH | New |
| CONTEXT THERAPEUTICS INC | COM | $920K | 0.1%Prev: 0.0% | 351,094 SH | Increased |
| CONTINEUM THERAPEUTICS INC | CL A | $3.6M | 0.2%Prev: 0.2% | 276,661 SH | Increased+107,896 SH |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $3.4M | 0.2% | 366,781 SH | New |
| CORCEPT THERAPEUTICS INC | COM | $322K | 0.0% | 8,000 SH | New |
| CORE SCIENTIFIC INC NEW | COM | $449K | 0.0% | 30,000 SH | New |
| CORVUS PHARMACEUTICALS INC | COM | $1.3M | 0.1% | 87,901 SH | New |
| COYA THERAPEUTICS INC | COMMON STOCK | $161K | 0.0% | 40,900 SH | New |
| CRESCENT BIOPHARMA INC. | COM | $924K | 0.1% | 50,273 SH | New |
| CRINETICS PHARMACEUTICALS IN | COM | $41.4M | 2.4%Prev: 0.3% | 1,139,331 SH | Increased+1,086,206 SH |
| CROWDSTRIKE HLDGS INC | CL A | $250K | 0.0% | 640 SH | New |
| CULLINAN THERAPEUTICS INC | COM | $711K | 0.0% | 50,000 SH | New |
| CYBIN INC | COM NEW | $150K | 0.0% | 31,278 SH | New |
| CYTOKINETICS INC | COM NEW | $41.7M | 2.5%Prev: 2.9% | 632,556 SH | Increased+241,827 SH |
| CYTOMX THERAPEUTICS INC. | COM | $16.0M | 0.9% | 3,410,190 SH | New |
| DAMORA THERAPEUTICS INC | COM NEW | $7.2M | 0.4% | 279,000 SH | New |
| DANAHER CORP DEL | COM | $5.9M | 0.3% | 30,932 SH | New |
| DAY ONE BIOPHARMACEUTICALS I | COM | $1.1M | 0.1%Prev: 0.0% | 49,923 SH | Increased+21,900 SH |
| DBV TECHNOLOGIES S A | SPONSORED ADS | $21.2M | 1.2% | 1,012,866 SH | New |
| DELCATH SYS INC | COM NEW | $2.1M | 0.1%Prev: 0.4% | 224,385 SH | Increased+75,000 SH |
| DENALI THERAPEUTICS INC | COM | $35.9M | 2.1%Prev: 0.0% | 1,871,455 SH | Increased+1,857,582 SH |
| DESIGN THERAPEUTICS INC | COM | $106K | 0.0% | 10,000 SH | New |
| DIANTHUS THERAPEUTICS INC | COM | $4.6M | 0.3%Prev: 0.1% | 55,000 SH | Increased+36,715 SH |
| DYNE THERAPEUTICS INC | COM | $861K | 0.1%Prev: 0.1% | 47,463 SH | Increased+17,364 SH |
| EA SERIES TRUST | ALPHA ARCH 1-3 | $39.2M | 2.3%Prev: 7.0% | 337,125 SH | Increased |
| EDGEWISE THERAPEUTICS INC | COM | $2.9M | 0.2%Prev: 0.1% | 90,599 SH | Increased+70,599 SH |
| ELANCO ANIMAL HEALTH INC | COM | $479K | 0.0% | 20,000 SH | New |
| ELECTRONIC ARTS INC | COM | $1.0M | 0.1% | 4,936 SH | New |
| ELEDON PHARMACEUTICALS INC | COM | $3.0M | 0.2%Prev: 0.0% | 974,421 SH | Increased+957,821 SH |
| ELI LILLY & CO | COM | $4.7M | 0.3%Prev: 0.1% | 5,060 SH | Increased+4,460 SH |
| ENANTA PHARMACEUTICALS INC | COM | $649K | 0.0% | 51,357 SH | New |
| ENGENE HOLDINGS INC | COM | $910K | 0.1%Prev: 0.0% | 133,686 SH | Increased+109,887 SH |
| ENLIVEN THERAPEUTICS INC | COM | $12.9M | 0.8% | 329,540 SH | New |
| ENTRADA THERAPEUTICS INC | COM | $385K | 0.0% | 30,500 SH | New |
| EQUILLIUM INC | COM | $7.5M | 0.4% | 3,726,659 SH | New |
| ERASCA INC | COM | $162K | 0.0% | 10,000 SH | New |
| ESPERION THERAPEUTICS INC NE | COM | $59K | 0.0% | 21,400 SH | New |
| ESTABLISHMENT LABS HLDGS INC | COM | $12.1M | 0.7%Prev: 0.1% | 213,473 SH | Increased+205,473 SH |
| EVOLUS INC | COM | $230K | 0.0% | 55,859 SH | New |
| EVOMMUNE INC | COM SHS | $4.2M | 0.2% | 184,062 SH | New |
| FORWARD AIR CORP | COM | $1.3M | 0.1% | 78,241 SH | New |
| FRACTYL HEALTH INC | COM | $654K | 0.0% | 1,428,571 SH | New |
| FULCRUM THERAPEUTICS INC | COM | $1.0M | 0.1%Prev: 0.3% | 130,560 SH | Decreased-359,972 SH |
| GERON CORP | COM | $298K | 0.0%Prev: 0.1% | 200,000 SH | Decreased-66,176 SH |
| GILEAD SCIENCES INC | COM | $885K | 0.1% | 6,351 SH | New |
| GLOBA TERRA ACQUISITION COR | UNIT 99/99/9999 | $518K | 0.0% | 50,000 SH | New |
| GLOBUS MED INC | CL A | $1.7M | 0.1% | 20,100 SH | New |
| GOSSAMER BIO INC | COM | $94K | 0.0%Prev: 0.0% | 287,531 SH | Decreased+60,303 SH |
| GUARDANT HEALTH INC | COM | $924K | 0.1% | 10,000 SH | New |
| HELIX ACQUISITION CORP III | USD CL A ORD SHS | $10.3M | 0.6% | 1,000,000 SH | New |
| IBIO INC | COM NEW | $893K | 0.1% | 469,878 SH | New |
| IDEAYA BIOSCIENCES INC | COM | $666K | 0.0% | 20,000 SH | New |
| IMMIX BIOPHARMA INC | COM | $91K | 0.0% | 10,000 SH | New |
| IMMUNOVANT INC | COM | $66.5M | 3.9%Prev: 3.1% | 2,679,010 SH | Increased+1,710,144 SH |
| INFLARX NV | COM | $142K | 0.0% | 158,271 SH | New |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $11.1M | 0.7%Prev: 2.1% | 6,606,572 SH | Decreased+1,484,467 SH |
| INOVIO PHARMACEUTICALS INC | COM SHS | $2.6M | 0.2% | 1,470,108 SH | New |
| INSMED INC | COM PAR $.01 | $5.8M | 0.3%Prev: 0.1% | 35,392 SH | Increased+29,318 SH |
| INSPIRE MED SYS INC | COM | $20.9M | 1.2% | 405,197 SH | New |
| INTEGER HLDGS CORP | COM | $770K | 0.0% | 8,750 SH | New |
| INTELLIA THERAPEUTICS INC | COM | $250K | 0.0% | 19,517 SH | New |
| INTUITIVE SURGICAL INC | COM NEW | $844K | 0.0%Prev: 0.1% | 1,830 SH | Increased+1,130 SH |
| INVENTIVA SA | ADS | $12.1M | 0.7% | 2,174,398 SH | New |
| INVIVYD INC | COM | $5.0M | 0.3% | 3,822,427 SH | New |
| IONIS PHARMACEUTICALS INC | COM | $12.0M | 0.7% | 160,338 SH | New |
| ISHARES TR | RUSSELL 2000 ETF | $6.8M | 0.4% | 27,500 SH | New |
| JADE BIOSCIENCES INC | COM NEW | $281K | 0.0% | 20,000 SH | New |
| JANUX THERAPEUTICS INC | COM | $4.1M | 0.2%Prev: 2.1% | 298,546 SH | Decreased-120,121 SH |
| JASPER THERAPEUTICS INC | COM NEW | $123K | 0.0% | 140,000 SH | New |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $567K | 0.0% | 3,000 SH | New |
| JD.COM INC | SPON ADS CL A | $296K | 0.0% | 10,000 SH | New |
| KALA BIO INC | COM NEW | $24K | 0.0%Prev: 0.3% | 141,480 SH | Decreased-157,475 SH |
| KALARIS THERAPEUTICS INC | COM | $577K | 0.0% | 100,000 SH | New |
| KALVISTA PHARMACEUTICALS INC | COM | $201K | 0.0%Prev: 0.1% | 10,000 SH | Decreased-25,743 SH |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $1.9M | 0.1% | 341,936 SH | New |
| KEEN VISION ACQUISITION CORP | SHS | $900K | 0.1% | 75,000 SH | New |
| KEROS THERAPEUTICS INC | COM | $1.1M | 0.1%Prev: 2.8% | 97,318 SH | Decreased-1,389,143 SH |
| KEZAR LIFE SCIENCES INC | COM NEW | $608K | 0.0%Prev: 0.1% | 81,933 SH | Decreased-65,471 SH |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | $1.3M | 0.1%Prev: 0.2% | 26,913 SH | Increased-14,499 SH |
| KIORA PHARMACEUTICALS INC | COM | $324K | 0.0%Prev: 0.1% | 167,941 SH | Decreased-26,724 SH |
| KORRO BIO INC | COM | $6.1M | 0.4%Prev: 0.2% | 540,054 SH | Increased+471,339 SH |
| KRYSTAL BIOTECH INC | COM | $5.2M | 0.3% | 20,014 SH | New |
| KURA ONCOLOGY INC | COM | $325K | 0.0%Prev: 0.0% | 40,000 SH | Increased+15,000 SH |
| KYNTRA BIO INC | COM NEW | $71K | 0.0% | 10,469 SH | New |
| KYVERNA THERAPEUTICS INC | COM | $194K | 0.0% | 22,428 SH | New |
| LARIMAR THERAPEUTICS INC | COM | $237K | 0.0% | 52,745 SH | New |
| LEGEND BIOTECH CORP | SPONSORED ADS | $362K | 0.0% | 20,000 SH | New |
| LEONABIO INC | COM | $7.5M | 0.4% | 727,481 SH | New |
| LEXEO THERAPEUTICS INC | COM | $8.4M | 0.5%Prev: 0.1% | 1,467,350 SH | Increased+1,296,902 SH |
| LEXICON PHARMACEUTICALS INC | COM NEW | $1.2M | 0.1% | 750,000 SH | New |
| LIPOCINE INC NEW | COM NEW | $185K | 0.0% | 23,180 SH | New |
| LIQUIDIA CORPORATION | COM NEW | $3.8M | 0.2% | 100,000 SH | New |
| LITE STRATEGY INC | COM | $78K | 0.0% | 67,292 SH | New |
| LONGEVERON INC | CL A NEW | $208K | 0.0% | 200,000 SH | New |
| MACROGENICS INC | COM | $116K | 0.0% | 40,000 SH | New |
| MADRIGAL PHARMACEUTICALS INC | COM | $469K | 0.0%Prev: 0.1% | 895 SH | Decreased-595 SH |
| MAPLIGHT THERAPEUTICS INC | COM | $7.6M | 0.4% | 374,909 SH | New |
| MASIMO CORP | COM | $2.7M | 0.2% | 15,000 SH | New |
| MAZE THERAPEUTICS INC | COM | $1.5M | 0.1% | 50,095 SH | New |
| MCKESSON CORP | COM | $1.0M | 0.1% | 1,200 SH | New |
| MERCK & CO INC | COM | $378K | 0.0% | 3,140 SH | New |
| MEREO BIOPHARMA GROUP PLC | SPON ADS | $50K | 0.0%Prev: 0.0% | 150,000 SH | Increased+140,000 SH |
| MILESTONE PHARMACEUTICALS IN | COM | $119K | 0.0% | 100,000 SH | New |
| MINERALYS THERAPEUTICS INC | COM | $4.2M | 0.2%Prev: 0.8% | 154,686 SH | Increased-108,739 SH |
| MIRUM PHARMACEUTICALS INC | COM | $573K | 0.0% | 6,200 SH | New |
| MONOPAR THERAPEUTICS INC | COM NEW | $14.5M | 0.9%Prev: 0.7% | 264,278 SH | Increased+163,504 SH |
| MONTE ROSA THERAPEUTICS INC | COM | $3.5M | 0.2% | 215,752 SH | New |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $8.9M | 0.5%Prev: 0.0% | 477,137 SH | Increased+471,713 SH |
| NATERA INC | COM | $429K | 0.0%Prev: 0.1% | 2,147 SH | Decreased-2,103 SH |
| NEKTAR THERAPEUTICS | COM NEW | $11.6M | 0.7% | 161,252 SH | New |
| NEUMORA THERAPEUTICS INC. | COM | $65K | 0.0%Prev: 0.0% | 33,100 SH | Increased+6,992 SH |
| NEUPHORIA THERAPEUTICS INC | COM | $122K | 0.0% | 30,000 SH | New |
| NEUROCRINE BIOSCIENCES INC | COM | $329K | 0.0% | 2,500 SH | New |
| NEURONETICS INC | COM | $145K | 0.0% | 100,000 SH | New |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $3.8M | 0.2% | 118,623 SH | New |
| NOVO-NORDISK A S | ADR | $1.7M | 0.1% | 46,000 SH | New |
| NURIX THERAPEUTICS INC | COM | $869K | 0.1%Prev: 0.0% | 56,070 SH | Increased+34,870 SH |
| NUVALENT INC | COM | $711K | 0.0% | 6,942 SH | New |
| NUVATION BIO INC | COM CL A | $187K | 0.0% | 43,500 SH | New |
| OAKTREE ACQUISITION CORP III | UNIT 10/04/2029 | $5.5M | 0.3%Prev: 1.0% | 516,482 SH | Increased |
| OMNIAB INC | COM | $1.1M | 0.1%Prev: 0.1% | 705,190 SH | Increased+579,082 SH |
| ONKURE THERAPEUTICS INC | COM CL A | $10.1M | 0.6%Prev: 0.0% | 2,434,941 SH | Increased+2,424,941 SH |
| OPUS GENETICS INC | COM | $8.4M | 0.5% | 1,849,004 SH | New |
| ORGANON & CO | COMMON STOCK | $60K | 0.0%Prev: 0.0% | 10,000 SH | Decreased |
| ORTHOPEDIATRICS CORP | COM | $315K | 0.0% | 19,845 SH | New |
| ORUKA THERAPEUTICS INC | COM | $1.0M | 0.1%Prev: 0.3% | 20,840 SH | Decreased-111,940 SH |
| OVID THERAPEUTICS INC | COM | $10.1M | 0.6%Prev: 0.0% | 4,544,113 SH | Increased+4,428,246 SH |
| PALISADE BIO INC | COM | $4.0M | 0.2% | 2,264,845 SH | New |
| PALO ALTO NETWORKS INC | COM | $257K | 0.0% | 1,600 SH | New |
| PEPGEN INC | COM | $2.8M | 0.2%Prev: 0.0% | 1,607,638 SH | Increased+1,587,286 SH |
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | $5.5M | 0.3%Prev: 1.4% | 499,581 SH | Decreased-250,419 SH |
| PERSONALIS INC | COM | $159K | 0.0% | 25,000 SH | New |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | $3.1M | 0.2% | 749,335 SH | New |
| PFIZER INC | COM | $2.2M | 0.1%Prev: 0.2% | 77,400 SH | Increased+36,350 SH |
| PHARVARIS N V | COM | $3.0M | 0.2% | 105,528 SH | New |
| PHATHOM PHARMACEUTICALS INC | COM | $477K | 0.0%Prev: 0.1% | 42,900 SH | Increased-10,000 SH |
| PLIANT THERAPEUTICS INC | COM | $3.3M | 0.2% | 2,585,126 SH | New |
| PMV PHARMACEUTICALS INC | COM | $286K | 0.0%Prev: 0.0% | 231,008 SH | Increased+130,000 SH |
| POLYPID LTD | COM | $455K | 0.0%Prev: 0.0% | 103,950 SH | Increased+23,870 SH |
| PRAXIS PRECISION MEDICINES I | COM NEW | $483K | 0.0% | 1,500 SH | New |
| PRELUDE THERAPEUTICS INC | COM | $523K | 0.0% | 152,825 SH | New |
| PRIME MEDICINE INC | COM | $6.9M | 0.4% | 1,973,282 SH | New |
| PROCAP ACQUISITION CORP | UNIT 05/16/2030 | $279K | 0.0% | 26,940 SH | New |
| PROMIS NEUROSCIENCES INC | COM SHS | $1.2M | 0.1% | 95,350 SH | New |
| PROQR THRAPEUTICS N V | SHS EURO | $16K | 0.0%Prev: 0.0% | 10,000 SH | Decreased-10,394 SH |
| PROTAGONIST THERAPEUTICS INC | COM | $104.8M | 6.2%Prev: 8.4% | 994,119 SH | Increased+54,450 SH |
| PROTARA THERAPEUTICS INC | COM STK | $4.9M | 0.3%Prev: 0.1% | 940,512 SH | Increased+817,822 SH |
| PROTHENA CORP PLC | SHS | $15.4M | 0.9% | 1,581,443 SH | New |
| PULMONX CORP | COM | $483K | 0.0% | 374,497 SH | New |
| Q/C TECHNOLOGIES INC | COM | $173K | 0.0% | 50,000 SH | New |
| Q32 BIO INC | COM | $225K | 0.0% | 35,000 SH | New |
| QUINCE THERAPEUTICS INC | COM | $10K | 0.0%Prev: 0.0% | 100,100 SH | Decreased-42,858 SH |
| RALLYBIO CORP | COM | $184K | 0.0%Prev: 0.0% | 20,535 SH | Increased+7,135 SH |
| RECURSION PHARMACEUTICALS IN | CL A | $107K | 0.0%Prev: 0.0% | 35,000 SH | Increased+20,000 SH |
| REGENERON PHARMACEUTICALS | COM | $9.4M | 0.6%Prev: 0.2% | 12,154 SH | Increased+10,793 SH |
| REGENXBIO INC | COM | $372K | 0.0%Prev: 0.5% | 44,416 SH | Decreased-305,936 SH |
| RELMADA THERAPEUTICS INC | COM | $3.1M | 0.2% | 451,918 SH | New |
| REPLIMUNE GROUP INC | COM | $12.9M | 0.8% | 1,682,987 SH | New |
| REVOLUTION MEDICINES INC | COM | $13.0M | 0.8%Prev: 1.2% | 133,893 SH | Increased-43,243 SH |
| REZOLUTE INC | COM NEW | $179K | 0.0%Prev: 0.6% | 58,679 SH | Decreased-1,057,368 SH |
| RHYTHM PHARMACEUTICALS INC | COM | $18.4M | 1.1%Prev: 0.4% | 211,450 SH | Increased+174,560 SH |
| ROCKET PHARMACEUTICALS INC | COM | $1.5M | 0.1%Prev: 0.3% | 432,500 SH | Decreased+190,700 SH |
| ROIVANT SCIENCES LTD | SHS | $91.0M | 5.4%Prev: 6.5% | 3,285,906 SH | Increased-197,498 SH |
| ROYALTY PHARMA PLC | SHS CLASS A | $240K | 0.0% | 5,000 SH | New |
| RUBRIK INC. | CL A | $240K | 0.0% | 4,900 SH | New |
| RXSIGHT INC | COM | $266K | 0.0% | 43,250 SH | New |
| SANOFI SA | SPONSORED ADR | $15.3M | 0.9% | 316,939 SH | New |
| SAREPTA THERAPEUTICS INC | COM | $5.7M | 0.3%Prev: 1.5% | 262,058 SH | Decreased+139,137 SH |
| SATELLOS BIOSCIENCE INC | COM | $1.3M | 0.1% | 222,555 SH | New |
| SAVARA INC | COM | $8.0M | 0.5%Prev: 0.7% | 1,464,535 SH | Increased+104,244 SH |
| SCHOLAR ROCK HLDG CORP | COM | $20.0M | 1.2%Prev: 0.9% | 407,273 SH | Increased+250,194 SH |
| SCHRODINGER INC | COM | $1.2M | 0.1% | 101,500 SH | New |
| SENSIENT TECHNOLOGIES CORP | COM | $1.3M | 0.1% | 15,000 SH | New |
| SEPTERNA INC | COM | $26.2M | 1.5%Prev: 0.8% | 1,089,818 SH | Increased+368,970 SH |
| SI BONE INC | COM | $159K | 0.0% | 12,580 SH | New |
| SILENCE THERAPEUTICS PLC | ADS | $907K | 0.1%Prev: 0.0% | 172,157 SH | Increased+153,514 SH |
| SOLENO THERAPEUTICS INC | COM | $1.6M | 0.1%Prev: 0.9% | 46,830 SH | Decreased-22,000 SH |
| SOLIDION TECHNOLOGY INC | COM NEW | $85K | 0.0% | 13,500 SH | New |
| SPDR SERIES TRUST | STATE STREET SPD | $14.3M | 0.8% | 150,585 SH | New |
| SPRUCE BIOSCIENCES INC | COM NEW | $3.8M | 0.2% | 58,600 SH | New |
| SPYRE THERAPEUTICS INC | COM NEW | $17.1M | 1.0%Prev: 0.0% | 338,323 SH | Increased+323,290 SH |
| STATE STR SPDR S&P 500 ETF T | TR UNIT | $49.4M | 2.9% | 75,940 SH | New |
| SUMMIT THERAPEUTICS INC | COM | $1.7M | 0.1%Prev: 0.4% | 91,869 SH | Decreased-8,131 SH |
| SUPERNUS PHARMACEUTICALS | COM | $1.5M | 0.1% | 29,642 SH | New |
| SURGERY PARTNERS INC | COM | $238K | 0.0%Prev: 0.2% | 20,000 SH | Decreased-20,000 SH |
| SURROZEN INC | COM NEW | $350K | 0.0% | 12,000 SH | New |
| SUTRO BIOPHARMA INC | COM SHS | $13.1M | 0.8% | 524,441 SH | New |
| SYNDAX PHARMACEUTICALS INC | COM | $409K | 0.0% | 17,500 SH | New |
| TANGO THERAPEUTICS INC | COM | $1.0M | 0.1%Prev: 0.0% | 50,000 SH | Increased+8,654 SH |
| TAYSHA GENE THERAPIES INC | COM SHS | $13.3M | 0.8%Prev: 0.3% | 2,979,429 SH | Increased+1,913,120 SH |
| TECTONIC THERAPEUTIC INC | COM | $402K | 0.0%Prev: 0.2% | 13,001 SH | Decreased-49,602 SH |
| TELEFLEX INCORPORATED | COM | $2.5M | 0.1% | 21,186 SH | New |
| TENAX THERAPEUTICS INC | COM NEW | $3.4M | 0.2%Prev: 0.1% | 213,462 SH | Increased+144,721 SH |
| TENAYA THERAPEUTICS INC | COM | $1.0M | 0.1% | 1,507,800 SH | New |
| TERNS PHARMACEUTICALS INC | COM | $58.8M | 3.5% | 1,114,699 SH | New |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | $8.1M | 0.5%Prev: 1.5% | 268,391 SH | Increased-255,376 SH |
| THE ONCOLOGY INSTITUTE INC | COM | $154K | 0.0% | 50,000 SH | New |
| THERAPEUTICSMD INC | COM NEW | $423K | 0.0%Prev: 0.0% | 209,210 SH | Increased-60,950 SH |
| TRAWS PHARMA INC | COM NEW | $282K | 0.0% | 154,098 SH | New |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $700K | 0.0% | 33,400 SH | New |
| UNIQURE NV | SHS | $2.9M | 0.2% | 176,206 SH | New |
| UNITEDHEALTH GROUP INC | COM | $1.5M | 0.1% | 5,501 SH | New |
| UPSTREAM BIO INC | COM | $315K | 0.0%Prev: 0.0% | 35,000 SH | Increased+20,000 SH |
| UROGEN PHARMA LTD | COM | $7.1M | 0.4% | 395,459 SH | New |
| VAXCYTE INC | COM | $15.1M | 0.9%Prev: 0.1% | 259,137 SH | Increased+246,337 SH |
| VERA THERAPEUTICS INC | CL A | $645K | 0.0% | 16,033 SH | New |
| VERASTEM INC | COM NEW | $377K | 0.0% | 71,100 SH | New |
| VERTEX PHARMACEUTICALS INC | COM | $6.7M | 0.4% | 15,075 SH | New |
| VERU INC | COM NEW | $77K | 0.0% | 35,000 SH | New |
| VIKING THERAPEUTICS INC | COM | $7.4M | 0.4%Prev: 0.3% | 227,717 SH | Increased+168,304 SH |
| VIR BIOTECHNOLOGY INC | COM | $24.6M | 1.4%Prev: 0.3% | 2,744,714 SH | Increased+2,494,714 SH |
| VIRIDIAN THERAPEUTICS INC | COM | $6.0M | 0.4%Prev: 0.2% | 304,422 SH | Increased+225,422 SH |
| VISTAGEN THERAPEUTICS INC | COM | $429K | 0.0%Prev: 0.2% | 751,141 SH | Decreased+330,376 SH |
| VOYAGER THERAPEUTICS INC | COM | $135K | 0.0%Prev: 0.0% | 35,000 SH | Decreased-40,545 SH |
| VYNE THERAPEUTICS INC | COM | $636K | 0.0%Prev: 0.0% | 1,063,899 SH | Increased+993,480 SH |
| WAVE LIFE SCIENCES LTD | SHS | $326K | 0.0%Prev: 0.0% | 44,900 SH | Increased+21,800 SH |
| WHITEHAWK THERAPEUTICS INC | COM | $443K | 0.0% | 128,503 SH | New |
| WISDOMTREE TR | FLOATNG RAT TREA | $503K | 0.0%Prev: 0.1% | 10,000 SH | Increased |
| WW INTL INC | COM NEW | $793K | 0.0% | 57,700 SH | New |
| XENCOR INC | COM | $1.1M | 0.1%Prev: 0.8% | 93,665 SH | Decreased-304,487 SH |
| XENON PHARMACEUTICALS INC | COM | $13.3M | 0.8%Prev: 0.8% | 228,899 SH | Increased+101,351 SH |
| ZAI LAB LTD | ADR | $26.8M | 1.6%Prev: 6.3% | 1,425,367 SH | Decreased+484,509 SH |
| ZENTALIS PHARMACEUTICALS INC | COM | $338K | 0.0% | 144,636 SH | New |
| ZURA BIO LTD | CLASS A ORD SHS | $3.8M | 0.2%Prev: 0.7% | 630,403 SH | Increased-2,170,781 SH |